29 July 2021 — GlaxoSmithKline plc (GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala…

Home »
29 July 2021 — GlaxoSmithKline plc (GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 30, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a…
NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that the U.S. Food and…